Toronto, ON, Canada
Biotechnology · DeepTech · Health
1 - 10 employees
Inteligex is developing proprietary stem cell-based therapeutics to restore function in patients with spinal cord injury— a devastating condition for which there is no effective therapy — and for other diseases of the Central Nervous System. Successful outcomes from the development program would position Inteligex as the first in the world with a treatment affecting hundreds of thousand patients worldwide.Something looks off?